Notas de prensa

La FDA otorga la designación de dispositivo innovador a dos pruebas rápidas dirigidas a patógenos críticos resistentes a medicamentos

MIGO Opportunities Trust plc - Net Asset Value(s)

Capital Gearing Trust P.l.c. - Net Asset Value(s)

Knight Therapeutics anuncia la solicitud de autorización regulatoria de NIKTIMVO® (axatilimab) en Brasil

HUMAIN Backs xAI with $3 Billion Series E Investment Ahead of Historic SpaceX Merger

48 Nations, One Arena: How Dubai United the World in Elite Tactical Showdown

Temple Bar Investment Trust Plc - Net Asset Value(s)

Finsbury Growth & Income Trust PLC - Net Asset Value(s)

Pacific Assets Trust plc - Net Asset Value(s)

BlackRock Smaller Companies Trust Plc - Net Asset Value(s)